Immunotherapy choice and maintenance for generalized myasthenia gravis in China.

Chao ZhangBitao BuHuan YangLihua WangWeibin LiuRui-Sheng DuanMeini ZhangPei ZengChen DuLi YangFu-Dong Shi

Published in: CNS neuroscience & therapeutics (2020)

Rituximab as monotherapy and tacrolimus with corticosteroids displayed better clinical efficacy as well as drug maintenance to prevent disease relapses in patients with generalized MG.

Keyphrases

myasthenia gravis
diffuse large b cell lymphoma
open label
randomized controlled trial